Breonics Plans 2012 Trial Of Combo Product Trial To Rehab Kidneys For Transplant
This article was originally published in The Gray Sheet
Executive SummaryOrgans donated from patients who died of strokes or heart attacks are not often used for transplant purposes. That is because the sudden cessation of blood flow kick-starts cell death and undermines the organ’s usefulness almost immediately.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.